D C Talbot Selected Research

D C Talbot Research Topics

Disease

7	Neoplasms (Cancer) 06/2011 - 07/2001
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 03/2001
3	Renal Cell Carcinoma (Grawitz Tumor) 11/2004 - 01/2000
3	Vomiting 01/2003 - 01/2000
2	Neutropenia 06/2003 - 05/2002
2	Melanoma (Melanoma, Malignant) 06/2000 - 01/2000
1	Ovarian Neoplasms (Ovarian Cancer) 01/2018
1	Necrosis 07/2004
1	Thrombocytopenia (Thrombopenia) 06/2003
1	Sleepiness 01/2003
1	Disease Progression 05/2002
1	Peripheral Nervous System Diseases (PNS Diseases) 05/2002
1	Breast Neoplasms (Breast Cancer) 05/2002
1	Myalgia 05/2002
1	Hand-Foot Syndrome 05/2002
1	Alopecia (Baldness) 05/2002
1	Bone Resorption 07/2001
1	Carcinoma (Carcinomatosis) 07/2000
1	Colorectal Neoplasms (Colorectal Cancer) 06/2000
1	Hypoxia (Hypoxemia) 06/2000

Drug/Important Bio-Agent (IBA)

4	Pharmaceutical PreparationsIBA 10/2003 - 01/2000
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2018 - 05/2002
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2004 - 07/2001
2	exatecan (DX 8951f)IBA 08/2003 - 06/2003
2	Cisplatin (Platino)FDA LinkGeneric 03/2001 - 06/2000
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 03/2001 - 06/2000
2	Vinblastine (Vinblastine Sulfate)FDA Link 03/2001 - 01/2000
2	Fluorouracil (Carac)FDA LinkGeneric 07/2000 - 06/2000
2	Dacarbazine (DIC)FDA LinkGeneric 06/2000 - 01/2000
2	Tamoxifen FDA LinkGeneric 06/2000 - 01/2000
1	vistusertibIBA 01/2018
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2018
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2011
1	Methotrexate (Mexate)FDA LinkGeneric 06/2011
1	Celecoxib (Celebrex)FDA Link 06/2011
1	Angiogenesis InhibitorsIBA 11/2004
1	Captopril (Capoten)FDA LinkGeneric 07/2004
1	marimastatIBA 07/2004
1	Dalteparin (Dalteparin Sodium)FDA Link 07/2004
1	tazarotene (Tazorac)FDA Link 09/2003
1	CamptothecinIBA 08/2003
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 08/2003
1	Topoisomerase I InhibitorsIBA 06/2003
1	Carbon-11IBA 01/2003
1	acridine DACAIBA 01/2003
1	BilirubinIBA 01/2003
1	Capecitabine (Xeloda)FDA Link 05/2002
1	AnthracyclinesIBA 05/2002
1	Matrix Metalloproteinase InhibitorsIBA 07/2001
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 07/2001
1	CGS 27023AIBA 07/2001
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2001
1	Matrix Metalloproteinases (MMPs)IBA 07/2001
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 07/2001
1	Urokinase Plasminogen Activator ReceptorsIBA 07/2001
1	Biological ProductsIBA 07/2001
1	CytokinesIBA 07/2001
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 07/2001
1	Tissue Inhibitor of Metalloproteinase-1IBA 07/2001
1	Tissue Inhibitor of Metalloproteinase-2IBA 07/2001
1	CathepsinsIBA 07/2001
1	RazoxaneIBA 12/2000
1	Topoisomerase II InhibitorsIBA 12/2000
1	Biomarkers (Surrogate Marker)IBA 12/2000
1	Interferon-alpha (Interferon Alfa)IBA 07/2000
1	Leucovorin (Folinic Acid)FDA Link 07/2000
1	Thymidine PhosphorylaseIBA 07/2000
1	Carmustine (FIVB)FDA Link 06/2000
1	5-(2-formyl-3-hydroxyphenoxy)pentanoic acidIBA 06/2000
1	AcidsIBA 06/2000
1	Oxygen (Dioxygen)IBA 06/2000
1	Toremifene (Fareston)FDA Link 01/2000
1	3-methyladenineIBA 01/2000
1	DNA (Deoxyribonucleic Acid)IBA 01/2000
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2000

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 01/2018 - 01/2000
4	Therapeutics 07/2004 - 06/2000
1	Immunotherapy 11/2004
1	Intravenous Infusions 06/2003
1	DBPT regimen 06/2000